

Globus Medical (NYSE:GMED) reported third-quarter financial results on Thursday. The transcript from the company’s third-quarter earnings call has been provided...
You can purchase shares of Globus Medical (NYSE:GMED) through any online brokerage.
Other companies in Globus Medical’s space includes: Abbott Laboratories (NYSE:ABT), Intuitive Surgical Inc (NASDAQ:ISRG), Medtronic PLC (NYSE:MDT), Stryker Corp (NYSE:SYK) and Boston Scientific Corp (NYSE:BSX).
Globus Medical has a consensus price target of $93.71.
The stock price for Globus Medical (NYSE: GMED) is $66.89 last updated November 20, 2026 at 4:00 PM EST.
There are no upcoming dividends for Globus Medical.
Globus Medical does not have any upcoming earnings scheduled.
There is no upcoming split for Globus Medical.
Globus Medical is in the Health Care sector and Health Care Equipment & Supplies industry. They are listed on the NYSE.
Through innovative technology and M&A activity, Globus Medical transformed into the number two medical device manufacturer in the competitive spine market. The firm was founded in 2003 with a heavy focus on internal research and development but...